Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1
Clinical trial NCT05520970 · TERMINATED
Trial details
- NCT number
- NCT05520970
- Sponsor
- Cellid Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-19
- Primary completion
- 2022-11-08
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.